Approval · Notice of Compliance 23339 · 2020
AG-MYCOPHENOLATE: Notice of Compliance 23339
Issued March 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23339
- Date
- March 16, 2020
- Company
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- CELLCEPT (Hoffmann-La Roche Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AG-MYCOPHENOLATE | 02497182 | Approved |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 500 MG per TAB